title: [Modern therapy of intestinal helminthiasis (author's transl)].
abstract: The modern chemotherapy of intestinal worm diseases is essentially based on niclosamide, thiabendazole and mebendazole. Thus an effective therapy with few side effects has become possible for these helminthiases. In infections with Taenia, Ascaris, Trichuris, Ankylostoma, Strongyloides, Trichostrongylus and Oxyuris, as the most frequently imported helminths, an elimination rate of over 90% of the parasites can be attained. Infections with nematode larvae as with Larva migrans and trichinoses are more problematic therapeutically because the anthelmintics are directed principally against the adult worms.
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D003551:Cysticercosis / Q000601:surgery; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use*; D009349:Nematode Infections / Q000188:drug therapy; D009534:Niclosamide / Q000627:therapeutic use*; D013827:Thiabendazole / Q000627:therapeutic use*
chemical_list: D001562:Benzimidazoles; D008463:Mebendazole; D009534:Niclosamide; D013827:Thiabendazole
vernacular_title: Die moderne Therapie der intestinalen Helminthosen.